Which cardiac parameters best predict the cardiovascular outcomes among patients with anti-PD-1 immunotherapy-induced myocardial injury?

Which cardiac parameters best predict the cardiovascular outcomes among patients with anti-PD-1 immunotherapy-induced myocardial injury?

AimTo explore the association of cardiac parameters with different clinical outcomes in patients with anti-PD-1 immunotherapy-induced myocardial injury.Methods and resultsWe screened 3,848 patients who received anti-PD-1 immunotherapy from June 2018 to Oct 2021 at the Second Xiangya Hospital of Cent...

Full description

Bibliographic Details
Main Authors:	Xiongjun Peng, Yawen Zheng, Zhaowei Zhu, Na Liu, Shenghua Zhou, Junke Long
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	cardiac parameters anti-PD-1 immunotherapy myocardial injury prognostic predictor cardiogenic death
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2022.922095/full

Similar Items

Predictors for early cardiac death after discharge from successfully treated acute myocardial infarction
by: Young Choi, et al.
Published: (2023-06-01)

Machine learning prediction of in-hospital recurrent infarction and cardiac death in patients with myocardial infarction
by: Yu. Kononova, et al.
Published: (2024-01-01)

Risk factors for postoperative myocardial injury-related cardiogenic shock in patients undergoing cardiac surgery
by: Xiao-Feng Cheng, et al.
Published: (2023-07-01)

Predictors Of Mortality In Patients With ST-Segment Elevation Acute Myocardial Infarction And Resuscitated Out-Of-Hospital Cardiac Arrest
by: Bărcan Andreea, et al.
Published: (2016-01-01)

Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer
by: Martín Núñez Abad, et al.
Published: (2022-01-01)

Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis
by: Fabio Scirocchi, et al.
Published: (2022-11-01)

Current Concepts and New Trends in the Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction
by: Benedek Theodora, et al.
Published: (2015-03-01)

Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis
by: Mina Karami, et al.
Published: (2020-06-01)

Epidemiological Trends in the Timing of In-Hospital Death in Acute Myocardial Infarction-Cardiogenic Shock in the United States
by: Saraschandra Vallabhajosyula, et al.
Published: (2020-07-01)

MANAGEMENT TACTICS FOR PATIENTS WITH CARDIOGENIC SHOCk DUE TO ACUTE MYOCARDIAL INFARCTION: EVIDENCE BASE, AND ACTUAL PRACTICE
by: S. R. Giliarevsky, et al.
Published: (2016-02-01)

The Predictive Value of Systemic Inflammatory Factors in Advanced, Metastatic Esophageal Squamous Cell Carcinoma Patients Treated with Camrelizumab
by: Liu J, et al.
Published: (2022-10-01)

PTMs of PD-1/PD-L1 and PROTACs application for improving cancer immunotherapy
by: Xiaohui Ren, et al.
Published: (2024-04-01)

PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations
by: Yongshuai Jiang, et al.
Published: (2019-05-01)

Mechanism and Clinical Application of PD-1/PD-L1 Inhibitors in Immunotherapy
by: Yang Xicheng
Published: (2022-01-01)

Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
by: Jia-Wen Cui, et al.
Published: (2024-02-01)

Cardiogenic shock as a first presentation in acute myocardial infarction in Egyptians patients and its outcome
by: Adel Hamed Elbaih, Ahmed G. Elsayed, Gamela M. Nasr, Mona M. Rayan
Published: (2018-03-01)

Predictors of acute kidney injury in patients with ST-segment elevation myocardial infarction complicated by cardiogenic shock who underwent percutaneous coronary intervention
by: O. V. Arsenicheva
Published: (2022-09-01)

Exercise sensitizes PD-1/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma
by: Huiyu Yan, et al.
Published: (2023-10-01)

Emerging role of ubiquitination/deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy
by: Peng Ding, et al.
Published: (2023-05-01)

Takotsubo Cardiomyopathy Occurring Simultaneously with Acute Myocardial Infarction
by: Ilija Srdanović, et al.
Published: (2023-08-01)

Novel nanotherapeutics for cancer immunotherapy by albumin nanoparticles functionalized with PD-1 and PD-L1 aptamers
by: Qiping Jiang, et al.
Published: (2024-01-01)

The importance of 18F-FDG cardiac PET/CT for the assessment of myocardial viability in ischaemic heart disease
by: Federico Caobelli, et al.
Published: (2021-06-01)

Two successive electrocardiograms of an old male with acute myocardial infarction: What on earth was going on?
by: Xiaoqing Wang, et al.
Published: (2022-09-01)

Comparison of Risk Models in the Prediction of 30-Day Mortality in Acute Myocardial Infarction–Associated Cardiogenic Shock
by: Lauren S. Ranard, MD, et al.
Published: (2022-11-01)

Frailty and In-Hospital Outcomes for Management of Cardiogenic Shock without Acute Myocardial Infarction
by: Dae Yong Park, et al.
Published: (2024-04-01)

Progress of research on PD-1/PD-L1 in leukemia
by: Huizhen Cao, et al.
Published: (2023-09-01)

DETERMINANTS OF MYOCARDIAL INFARCTION OUTCOMES IN A NON-PERCUTANEOUS CORONARY INTERVENTION HOSPITAL IN JAKARTA
by: Talitha Syifa Laili, et al.
Published: (2023-11-01)

Complete percutaneous myocardial revascularization in patients with STEMI complicated by cardiogenic shock
by: Petrović Milovan, et al.
Published: (2019-01-01)

Immune Checkpoint Inhibitors: Ctla-4 and Pd-1/Pd-l1 in Immunotherapy
by: Kübra KAHVECİ, et al.
Published: (2019-12-01)

Involvement of Vasopressin in Tissue Hypoperfusion during Cardiogenic Shock Complicating Acute Myocardial Infarction in Rats
by: Philippe Gaudard, et al.
Published: (2023-01-01)

Differences between cardiogenic shock related to acute decompensated heart failure and acute myocardial infarction
by: Maurizio Bertaina, et al.
Published: (2023-12-01)

Comparing the associations between host and tumor factors with survival outcomes with anti‐PD‐1 immunotherapy in metastatic melanoma
by: Kim Koczka, et al.
Published: (2023-02-01)

Pre-percutaneous coronary intervention sudden cardiac arrest in ST-elevation myocardial infarction: Incidence, predictors, and related outcomes
by: Guilherme Pinheiro Machado, et al.
Published: (2023-02-01)

Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers
by: Liping Pei, et al.
Published: (2023-02-01)

Research Advances of Immunotherapy of Exosome PD-L1  in Non-small Cell Lung Cancer
by: Na WANG, et al.
Published: (2022-09-01)

Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
by: Danilo Rocco, et al.
Published: (2023-09-01)

Cardiogenic Shock Clinical Presentation, Management, and In-Hospital Outcomes in Patients Admitted to the Acute Cardiac Care Unit of a Tertiary Hospital: Does Gender Play a Role?
by: Adrian Jerónimo, et al.
Published: (2020-09-01)

Contemporary Management of Cardiogenic Shock Complicating Acute Myocardial Infarction
by: Leonardo De Luca, et al.
Published: (2023-03-01)

Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
by: Jacob Eifer Møller, et al.
Published: (2022-04-01)

Recurrent Multivessel Coronary Artery Spasm Presented as Myocardial Infarction
by: Hao Zhang, et al.
Published: (2016-01-01)